METADOS

METADOS

TBA
1,698 Views
MetaDOS - BattleRoyale ESPORT & TOURNAMENT Explore a growing roster of powerful Players, each with their own unique personality, strengths, and abilities. OWN YOUR NFTS Your game items, such as skins and lands, are also your own NFTs. You can trade them or even use them on other games on DOS. SKILL & TIME Master powerful weapons, unique abilities, and your own Time (Your own life).
1.4
TOTAL SCORE
1.9
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Dates: TBA
Token info
Ticker: METADOS
Platform: Unknown
Financial
Social media
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Pre-Sale
UNIMOON
“You’ve got to start with the customer experience and work backwards to the technology. You can’t start with the technology and try to figure out where can I sell it.” -Steve Jobs UNIMOON is tokenizing on Polygon Matic. We are building a layer 1 solution building on substrate and auction for a Polkadot parachain. We will be the first interoperable decentralized social media network partnering with Storj for our decentralized cloud data storage needs. Enabling users to have full ownership and control of their personal information where it is displayed and how it is displayed utilizing blockchain technology for storage of key information. UNIMOON is bridging the gap between web2.0 to web3.0 solving the greatest issue of adoption for blockchain technology in the simplest way possible starting with the user experience.
Upcoming
Collectible
Collectible is the exclusive NFT + Physical Item online platform out there. It’s one of a kind. Just like its items. With different unannounced drops happening every week ranging from sport memorabilia to long century old art brought back to life through our NFT creating process making it relevant again. Through our top-notch blockchain technology and NFT creating service we provide a level of authenticity to users that hasn't been seen since the beginning of the internet.
Upcoming
Vidy
Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.
Upcoming
Connecty.io
Connecty is looking to streamline the relationship between businesses and research house by serving as the missing link between holders of knowledge and those responsible for transforming knowledge into innovation. This knowledge ecosystem is setting out to accommodate all scenarios on the spectrum: from a short request for an expert’s opinion to a comprehensive research study that may stretch over a considerable period of time. It is intended this will be open to all areas of knowledge and all fields of study ranging from physics, engineering and IT systems to ecology, environment and society plus everything in between.
Upcoming
Talao
Talao is the first Ethereum-based DAO for Talent, which introduces a unique way for users to own their data thanks to a secure digital vault storing their certificates on the blockchain. Talao provides a decentralized marketplace, governed by Talent, on which neither intermediaries nor commissions apply.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.